Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

7.99
Delayed Data
As of 3:59pm ET
 -0.01 / -0.12%
Today’s Change
6.60
Today|||52-Week Range
10.83
-18.47%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close8.00
Today’s open8.12
Day’s range7.82 - 8.18
Volume65,719
Average volume (3 months)31,190
Market cap$181.7M
Dividend yield--
Data as of 3:59pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-19.44%
Earnings growth (next 5 years)-6.32%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd+0.06+0.85%
OSIROsiris Therapeutics ...+0.27+5.21%
CYTRCytRx Corp+0.18+6.92%
AXSMAxsome Therapeutics ...-0.35-3.40%
Data as of 3:59pm ET, 05/24/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Vice President-
Operations
Yariv Gratz
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Partner Offers

Search for Jobs